Robert Gundel

Robert Gundel

No open positions remaining
Health Technology
Consumer Services
Finance

Profile

Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.

Former positions of Robert Gundel

CompaniesPositionEnd
PROMIS NEUROSCIENCES, INC. Chief Executive Officer 29/06/2015
SCORPIUS HOLDINGS, INC. Chief Tech/Sci/R&D Officer 01/01/2009
Chief Tech/Sci/R&D Officer 01/11/2008
Chief Tech/Sci/R&D Officer 01/01/2008
Corporate Officer/Principal 01/01/2007
See the detail of Robert Gundel's experience

Training of Robert Gundel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

24

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance